Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001628280-23-008833

Chief Financial Officer acquired 176,191 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shah Mihir Chief Financial Officer 2023-03-17 Grant or award +176,191 226,914 D
Derivatives
Shah Mihir Chief Financial Officer 2023-03-17 Grant or award · Non-Qualified Stock Option (right to buy) +440,477 440,477 D
Loading xslF345X04/wf-form4_167944679255330.xml…